Despite recent claims, the FDA has issued a warning to women who undergo breast cancer screening: Do not replace mammograms with thermograms.
National Research Center of Women & Families President Diana Zuckerman testifies at the FDA meeting on Avastin.
National Research Center of Women & Families President Diana Zuckerman testifies at the FDA meeting on Avastin.
Washington Post, Letters to the Editor, August 22, 2010. If a breast cancer patient takes Avastin, it will not improve her chances of living longer, but her quality of life is more likely to be harmed because of the debilitating conditions linked to the drug.
Keeping track of calories and fat percentages can be confusing, and the nutrition labels on the foods we buy aren’t always that helpful. How are consumers supposed to figure out which diet advice is just hype – that ultimately don’t contribute to better health – and which advice offers good, medically sound information?